Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01696
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 10, 2020
Authors
Publisher
Frontiers Media SA